(Q42246155)

English

Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies

scientific article published on 27 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Nicoline van der Maas

2

object named as

Nicoline van der Maas

0 references

4

object named as

Frits R Mooi

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hester E. de Melker

5

object named as

Hester E de Melker

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Anna K Lugnér

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Nicoline van der Maas

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Michiel van Boven

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

27 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

5392-5397

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Deaths from pertussis are underestimated in England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Rationale for pertussis booster vaccination throughout life in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Clinical and economic assessment of different general population strategies of pertussis vaccine booster regarding number of doses and age of application for reducing whooping cough disease burden: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Acellular vaccines for preventing whooping cough in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Waning protection after fifth dose of acellular pertussis vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Pertussis disease burden in the household: how to protect young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Infant pertussis: who was the source?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Economic analysis of pertussis illness in the Dutch population: implications for current and future vaccination strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Health-state valuations for pertussis: methods for valuing short-term health states

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Natural history of pertussis antibody in the infant and effect on vaccine response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Pertussis vaccination strategies for neonates--an exploratory cost-effectiveness analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Development of improved vaccines against whooping cough: current status.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Cost-effectiveness of pertussis booster vaccination in the Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Efficacy of an acellular pertussis vaccine among adolescents and adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

[Pertussis: incidence, symptoms and costs]

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

Survey of pertussis morbidity in adults in western Sydney.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.028

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2013.09.028

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42246155&oldid=1939805371"